Actinomyces odontolyticus:在腹腔透析中,一种罕见的出口部位感染的病原体
Mariana Freitas1, Bárbara Beirão Rodrigues1, Luís Oliveira1
1Nephrology, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, PRT.
Cureus
|January 23, 2025
概括
腹膜透析导管的出口部位感染 (ESI) 可能是严重的. 这一案例表明,多西环林有效地治疗了一种罕见的Actinomyces odontolyticus感染,避免了导管切除.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 出口部位感染 (ESI) 是腹膜透析 (PD) 的常见并发症.
- 及时治疗对于预防严重并发症和潜在的导管损失至关重要.
- 不常见的病原体可能导致ESI,使诊断和治疗复杂化.
研究的目的:
- 报告一种由Actinomyces odontolyticus引起的PD-ESI病例.
- 强调识别罕见病原体对于有效治疗的重要性.
- 为了突出PD-ESI的成功管理,有针对性的抗生素治疗.
主要方法:
- 一个26岁的女性患有末期脏疾病的病例报告.
- 最初的阴性培养和经验性的科特里莫克萨治疗.
- 复发导致了对Actinomyces odontolyticus的无氧培养物鉴定.
- 抗生素敏感性测试显示了对包括青素在内的多种药物的耐药性.
- 开始使用多西环林治疗.
主要成果:
- 在复发时,Actinomyces odontolyticus被确定为致病剂.
- 该病原体对几种抗生素表现出耐药性.
- 多西环林治疗导致感染在四周内消失.
- 腹膜透析导管被保留了.
- 在六个月的随访期内没有观察到复发.
结论:
- 早期诊断和量身定制的抗生素治疗对于管理罕见的PD-ESI至关重要.
- 与微生物学实验室的合作对于识别非典型病原体至关重要.
- 有针对性的治疗可以带来有利的结果,并可能避免取出导管.
相关概念视频
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...


